Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG.

Suppr

超能文献

作者信息

Eichberg J W, Murthy K K, Ward R H, Prince A M

机构信息

Southwest Foundation for Biomedical Research, San Antonio, TX 78228.

出版信息

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1515. doi: 10.1089/aid.1992.8.1515.

DOI:10.1089/aid.1992.8.1515

PMID:1466993

Abstract

摘要

相似文献

Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1515. doi: 10.1089/aid.1992.8.1515.

Prevention of HIV infection by passive immunization with HIV immunoglobulin.用HIV免疫球蛋白进行被动免疫预防HIV感染。

AIDS Res Hum Retroviruses. 1991 Dec;7(12):971-3. doi: 10.1089/aid.1991.7.971.

Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin.CD4免疫粘附素预防黑猩猩感染HIV-1 IIIB毒株。

Nature. 1991 Aug 1;352(6334):434-6. doi: 10.1038/352434a0.

AIDS. Passive primate protection.艾滋病。被动的灵长类动物保护。

Nature. 1991 Aug 1;352(6334):376-7. doi: 10.1038/352376a0.

Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors.来自人类免疫缺陷病毒血清阳性供体的IgG静脉溶液的制备与表征

Blood. 1991 Mar 1;77(5):1111-7.

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).人类免疫缺陷病毒（HIV）人高免疫球蛋白在1型HIV感染儿童中的应用（儿科艾滋病临床试验组方案273）

J Infect Dis. 2000 Feb;181(2):548-54. doi: 10.1086/315224.

Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg).治疗用正常人免疫球蛋白G（静脉注射免疫球蛋白，IVIg）的抗CD4活性。

Ther Immunol. 1994 Oct;1(5):269-77.

Will sialylation change intravenous immunoglobulin therapy in the future?唾液酸化未来会改变静脉注射免疫球蛋白疗法吗？

Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):100-2. doi: 10.1111/cei.12528.

Passive immunization for the treatment and prevention of HIV infection.

Biotechnol Ther. 1991;2(1-2):31-48.

Dose and outcomes in primary immunodeficiency disorders.原发性免疫缺陷病的剂量与结局

Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):7-9. doi: 10.1111/cei.12492.

引用本文的文献

CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals.CD4 结合位点免疫原在转基因和野生型动物中引发了针对 HIV-1 的异源中和抗体。

Sci Immunol. 2023 Feb 17;8(80):eade6364. doi: 10.1126/sciimmunol.ade6364. Epub 2023 Feb 10.

Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env.恒河猴的序贯免疫可诱导针对 HIV-1 Env 的 V3-聚糖补丁的异源中和抗体。

Sci Transl Med. 2021 Nov 24;13(621):eabk1533. doi: 10.1126/scitranslmed.abk1533.

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic.推进 HIV 广谱中和抗体的研发：从发现到临床应用。

Front Public Health. 2021 May 26;9:690017. doi: 10.3389/fpubh.2021.690017. eCollection 2021.

A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch.一种针对 HIV-1 V3-聚糖补丁的广谱中和猕猴单克隆抗体。

Elife. 2020 Oct 21;9:e61991. doi: 10.7554/eLife.61991.

Progress toward active or passive HIV-1 vaccination.HIV-1主动或被动疫苗接种的进展。

J Exp Med. 2017 Jan;214(1):3-16. doi: 10.1084/jem.20161765. Epub 2016 Dec 21.

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.恒河猴经多克隆抗 HIV IgG 被动免疫针对异源 tier 2 SHIV：结果取决于 IgG 剂量。

Retrovirology. 2014 Jan 20;11:8. doi: 10.1186/1742-4690-11-8.

Antibodies in HIV-1 vaccine development and therapy.HIV-1 疫苗开发和治疗中的抗体。

Science. 2013 Sep 13;341(6151):1199-204. doi: 10.1126/science.1241144.

Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.作为进入介质、疫苗免疫原和抑制剂靶点的HIV包膜糖蛋白的结构与功能

Adv Pharmacol. 2007;55:33-97. doi: 10.1016/S1054-3589(07)55002-7.

Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.来自多克隆人免疫缺陷病毒（HIV）免疫球蛋白的免疫球蛋白G3在中和1型HIV方面比其他亚类更有效。

J Virol. 2001 Jul;75(14):6558-65. doi: 10.1128/JVI.75.14.6558-6565.2001.

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.通过中和抗体的被动转移保护猕猴免受致病性猿猴/人类免疫缺陷病毒89.6PD的侵害。

J Virol. 1999 May;73(5):4009-18. doi: 10.1128/JVI.73.5.4009-4018.1999.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验